Concordance of angiographic and electrocardiographic indexes of microvascular obstruction: myocardial haemorrhage role
暂无分享,去创建一个
A. M. Leone | F. Burzotta | C. Trani | G. Niccoli | I. Porto | F. Crea | L. Bonomo | L. Natale | F. Fracassi | A. Lombardo | N. Cosentino | C. Calvieri | M. Roberto | V. Loria | C. Spaziani | C. Napolitano | Alessandro Mandurinoa | A. Leone
[1] S. Plein,et al. Relationship of cardiac biomarkers and reversible and irreversible myocardial injury following acute myocardial infarction as determined by cardiovascular magnetic resonance. , 2013, International journal of cardiology.
[2] E. Romagnoli,et al. Open-label, randomized, placebo-controlled evaluation of intracoronary adenosine or nitroprusside after thrombus aspiration during primary percutaneous coronary intervention for the prevention of microvascular obstruction in acute myocardial infarction: the REOPEN-AMI study (Intracoronary Nitropruss , 2013, JACC. Cardiovascular interventions.
[3] R. Kim,et al. Controversies in cardiovascular MR imaging: T2-weighted imaging should not be used to delineate the area at risk in ischemic myocardial injury. , 2012, Radiology.
[4] R. Erbel,et al. Lessons from human coronary aspirate. , 2012, Journal of molecular and cellular cardiology.
[5] Mihaela Pop,et al. Quantitative tracking of edema, hemorrhage, and microvascular obstruction in subacute myocardial infarction in a porcine model by MRI , 2011, Magnetic resonance in medicine.
[6] S. Plein,et al. Timing of cardiovascular MR imaging after acute myocardial infarction: effect on estimates of infarct characteristics and prediction of late ventricular remodeling. , 2011, Radiology.
[7] F. Burzotta,et al. Angiographic patterns of myocardial reperfusion after primary angioplasty and ventricular remodeling , 2011, Coronary artery disease.
[8] G. Schuler,et al. Prognostic value and determinants of a hypointense core in T2-weighted cardiac magnetic resonance in acute reperfused ST-elevation myocardial infarction , 2011, Circulation. Cardiovascular imaging.
[9] J. Lima,et al. MRI in acute myocardial infarction. , 2011, European heart journal.
[10] D. O’Regan,et al. Assessment of severe reperfusion injury with T2* cardiac MRI in patients with acute myocardial infarction , 2010, Heart.
[11] J. Tijssen,et al. Prediction of 1-Year Mortality With Different Measures of ST-Segment Recovery in All-Comers After Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction , 2010, Circulation. Cardiovascular quality and outcomes.
[12] M. Friedrich,et al. Hemorrhage in the myocardium following infarction. , 2010, JACC. Cardiovascular imaging.
[13] R. Virmani,et al. Microvascular obstruction: underlying pathophysiology and clinical diagnosis. , 2010, Journal of the American College of Cardiology.
[14] L. Badimón,et al. Controlling the angiogenic switch in developing atherosclerotic plaques: Possible targets for therapeutic intervention , 2009, Journal of angiogenesis research.
[15] F. Burzotta,et al. Myocardial no-reflow in humans. , 2009, Journal of the American College of Cardiology.
[16] F. Van de Werf,et al. Impact of myocardial haemorrhage on left ventricular function and remodelling in patients with reperfused acute myocardial infarction. , 2009, European heart journal.
[17] K. Dickstein,et al. C-reactive protein, infarct size, microvascular obstruction, and left-ventricular remodelling following acute myocardial infarction. , 2009, European heart journal.
[18] Joseph V Hajnal,et al. Reperfusion hemorrhage following acute myocardial infarction: assessment with T2* mapping and effect on measuring the area at risk. , 2009, Radiology.
[19] R. Kloner,et al. Coronary no‐reflow phenomenon: From the experimental laboratory to the cardiac catheterization laboratory , 2008, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[20] S. Butman,et al. The pathogenesis and treatment of no-reflow occurring during percutaneous coronary intervention. , 2008, Cardiovascular revascularization medicine : including molecular interventions.
[21] Harlan M Krumholz,et al. Time to treatment in primary percutaneous coronary intervention. , 2007, The New England journal of medicine.
[22] S. Iliceto,et al. Morphologic validation of reperfused hemorrhagic myocardial infarction by cardiovascular magnetic resonance. , 2007, The American journal of cardiology.
[23] E. Stępień,et al. No-Reflow Phenomenon After Acute Myocardial Infarction Is Associated With Reduced Clot Permeability and Susceptibility to Lysis , 2007, Arteriosclerosis, thrombosis, and vascular biology.
[24] E. Romagnoli,et al. Relation of myocardial blush grade to microvascular perfusion and myocardial infarct size after primary or rescue percutaneous coronary intervention. , 2007, American Journal of Cardiology.
[25] R. Kloner,et al. The no-reflow phenomenon: A basic mechanism of myocardial ischemia and reperfusion , 2006, Basic Research in Cardiology.
[26] E. Romagnoli,et al. Endothelin-1 and acute myocardial infarction: a no-reflow mediator after successful percutaneous myocardial revascularization. , 2006, European heart journal.
[27] R. Blindt,et al. Association of C-reactive protein and myocardial perfusion in patients with ST-elevation acute myocardial infarction. , 2006, Atherosclerosis.
[28] G. Thiene,et al. The pathophysiology of myocardial reperfusion: a pathologist’s perspective , 2006, Heart.
[29] J. Núñez,et al. Usefulness of a comprehensive cardiovascular magnetic resonance imaging assessment for predicting recovery of left ventricular wall motion in the setting of myocardial stunning. , 2005, Journal of the American College of Cardiology.
[30] G. Montalescot,et al. The acute reperfusion management of STEMI in patients with impaired glucose tolerance and type 2 diabetes , 2005, Diabetes & vascular disease research.
[31] B. Gersh,et al. Combined prognostic utility of ST-segment recovery and myocardial blush after primary percutaneous coronary intervention in acute myocardial infarction. , 2005, European heart journal.
[32] E. Antman,et al. Angiographic perfusion score: an angiographic variable that integrates both epicardial and tissue level perfusion before and after facilitated percutaneous coronary intervention in acute myocardial infarction. , 2004, American heart journal.
[33] E. Antman,et al. Combined assessment of thrombolysis in myocardial infarction flow grade, myocardial perfusion grade, and ST-segment resolution to evaluate epicardial and myocardial reperfusion. , 2004, The American journal of cardiology.
[34] G. Parodi,et al. Impact of Microvascular Dysfunction on Left Ventricular Remodeling and Long-Term Clinical Outcome After Primary Coronary Angioplasty for Acute Myocardial Infarction , 2004, Circulation.
[35] L. Galiuto. Optimal therapeutic strategies in the setting of post-infarct no reflow: the need for a pathogenetic classification , 2004, Heart.
[36] J. Schulz-Menger,et al. Detection of Acutely Impaired Microvascular Reperfusion After Infarct Angioplasty With Magnetic Resonance Imaging , 2003, Circulation.
[37] R. Testa,et al. Platelet glycoprotein IIb/IIIa receptor blockade and coronary resistance in unstable angina. , 2002, Journal of the American College of Cardiology.
[38] Katherine C. Wu,et al. Accuracy of Contrast-Enhanced Magnetic Resonance Imaging in Predicting Improvement of Regional Myocardial Function in Patients After Acute Myocardial Infarction , 2002, Circulation.
[39] S. de Servi,et al. Integrated Analysis of Myocardial Blush and ST-Segment Elevation Recovery After Successful Primary Angioplasty: Real-Time Grading of Microvascular Reperfusion and Prediction of Early and Late Recovery of Left Ventricular Function , 2002, Circulation.
[40] George Dangas,et al. Impact of normalized myocardial perfusion after successful angioplasty in acute myocardial infarction. , 2002, Journal of the American College of Cardiology.
[41] R. Gibbons,et al. TIMI Myocardial Perfusion Grade and ST Segment Resolution: Association With Infarct Size as Assessed by Single Photon Emission Computed Tomography Imaging , 2002, Circulation.
[42] M. Brownlee. Biochemistry and molecular cell biology of diabetic complications , 2001, Nature.
[43] Katherine C. Wu,et al. Microvascular obstruction and left ventricular remodeling early after acute myocardial infarction. , 2000, Circulation.
[44] M. Pepys,et al. C-Reactive Protein and Complement Are Important Mediators of Tissue Damage in Acute Myocardial Infarction , 1999, The Journal of experimental medicine.
[45] Katherine C. Wu,et al. Quantification and time course of microvascular obstruction by contrast-enhanced echocardiography and magnetic resonance imaging following acute myocardial infarction and reperfusion. , 1998, Journal of the American College of Cardiology.
[46] K. Iwakura,et al. Assessing the relation between coronary reflow and myocardial reflow. , 1998, The American journal of cardiology.
[47] H. Suryapranata,et al. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Zwolle Myocardial Infarction Study Group. , 1998, Circulation.
[48] M. Ovize,et al. A fresh look at reperfusion injury. , 1998, Cardiovascular research.
[49] L. Barrios,et al. Infarct size, myocardial hemorrhage, and recovery of function after mechanical versus pharmacological reperfusion: effects of lytic state and occlusion time. , 1997, Circulation.
[50] M. Hori,et al. Clinical implications of the 'no reflow' phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. , 1996, Circulation.
[51] K Wegscheider,et al. Extent of early ST segment elevation resolution: a strong predictor of outcome in patients with acute myocardial infarction and a sensitive measure to compare thrombolytic regimens. A substudy of the International Joint Efficacy Comparison of Thrombolytics (INJECT) trial. , 1995, Journal of the American College of Cardiology.
[52] W. O’Neill,et al. Features and outcome of no-reflow after percutaneous coronary intervention. , 1995, The American journal of cardiology.
[53] K. Wegscheider,et al. Extent of early ST segment elevation resolution: a simple but strong predictor of outcome in patients with acute myocardial infarction. , 1994, Journal of the American College of Cardiology.
[54] D. Baim,et al. Incidence and treatment of 'no-reflow' after percutaneous coronary intervention. , 1994, Circulation.
[55] S. Bishop,et al. Assessment of Postreperfusion Myocardial Hemorrhage Using Proton NMR Imaging at 1.5 T , 1992, Circulation.
[56] A. Kitabatake,et al. Lack of Myocardial Perfusion Immediately After Successful Thrombolysis: A Predictor of Poor Recovery of Left Ventricular Function in Anterior Myocardial Infarction , 1992, Circulation.
[57] F. Fernández‐Avilés,et al. Determinants of hemorrhagic infarcts. Histologic observations from experiments involving coronary occlusion, coronary reperfusion, and reocclusion. , 1990, The American journal of pathology.
[58] N. Reichek,et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. , 1989, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[59] T. Carew,et al. The effect of acute hypercholesterolemia on myocardial infarct size and the no-reflow phenomenon during coronary occlusion-reperfusion. , 1987, Circulation.
[60] W. Ganz,et al. The thrombolysis in myocardial infarction (TIMI) trial. , 1985, The New England journal of medicine.
[61] H. S. Mueller,et al. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. , 1985, The New England journal of medicine.
[62] D. Durrer,et al. Tissue Osmolality, Cell Swelling, and Reperfusion in Acute Regional Myocardial Ischemia in the Isolated Porcine Heart , 1981, Circulation research.